Boundless Bio logo

Boundless Bio

BOLD | NASDAQ
Chart Builder DCF Calculator
$2.41
-$0.09 (-3.60%)
At close: Nov 16, 2026, 4:00 PM ET
$2.39
-$0.02 (-0.83%)
After-hours: Nov 16, 2026, 6:23 PM ET
-3.60%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
28.2
+1.4 pts
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #837/1021 (Top 82%)

Key Statistics

Market Data

Market Cap $56.9M
1D Range
2.40 2.50
52W Range
1.05 3.00

Valuation (TTM)

PE -0.98
PB 0.92
EV/EBITDA 0.11

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $0.00
Loading financial charts...

Profile

Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Th...

Sector Healthcare
Industry Biotechnology
Employees 28
IPO Date Mar 28, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.